Please find attached the outcome of the Board Meeting held on 13th November, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kkalpana Industries' board approved unaudited standalone results for Q2 and H1 FY26 (ended 30 September 2025). Revenue from operations fell sharply to Rs 725.22 lakhs in Q2 (from Rs 1,310.84 lakhs YoY) and Rs 1,666.89 lakhs in H1 (from Rs 2,403.98 lakhs YoY), a ~31% decline for the half-year. Total income was propped up by a sharp jump in 'other income' to Rs 869.74 lakhs in H1 (vs Rs 637.21 lakhs), driven mainly by a Rs 816 lakh profit on sale of investment property. Profit after tax surged to Rs 74.79 lakhs in H1 (vs Rs 35.63 lakhs), helped by lower operating expenses and tax adjustments. On the balance sheet, the company fully repaid its long-term borrowings of Rs 2,500 lakhs, strengthening the equity position. Operating cash flow remained healthy at Rs 1,548 lakhs.
Mixed signals for shareholders: core business revenue is contracting meaningfully, but the company has cleaned up its balance sheet by wiping out long-term debt and reported higher PAT. Investors should watch whether the revenue decline stabilises, as much of the bottom-line boost came from one-time property sale gains rather than operations.